HCA Healthcare Retains Positive Analyst Ratings Despite Price Decline HCA Healthcare has received a consensus "Moderate Buy" rating from analysts, even as its stock price has dropped recently. The company reported strong quarterly earnings, exceeding expectations, and increased its dividend payout. Analysts' average price target for HCA shares stands at $385.67, reflecting continued confidence in its long-term performance.3